There are 2789 resources available
The value of genomics information for trial design
Presenter: Edwin Cuppen
Session: Biology-guided combination cancer therapy
Resources:
Slides
Webcast
Combining immunotherapy and kinase inhibition
Presenter: Anna Obenauf
Session: Biology-guided combination cancer therapy
Resources:
Slides
Webcast
Introduction and presentation of case/condition
Presenter: Peter Schmid
Session: Managing a challenging situation in metastatic breast cancer patients treated with immunotherapy
Resources:
Slides
Introduction and presentation of case/condition 1: TNBC
Presenter: Peter Dubsky
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Presentation of case/condition 2: HER2+ BC
Presenter: Frederik Marmé
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Tailored surgical therapy after NACT
Presenter: Chin-Sheng Hung
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Tailored systemic therapy after NACT
Presenter: Frederik Marmé
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Neurological complications of immunotherapy: Diagnosis and treatment
Presenter: Andreas Hottinger
Session: Neurological complications of cancer treatment
Resources:
Slides
Webcast
To add or not to add systemic treatment
Presenter: Sandrine Faivre
Session: When and how should age influence treatment
Resources:
Slides
Webcast
Presentation of case/condition 2: Old patient with locally advanced HPV positive disease
Presenter: Paolo Bossi
Session: When and how should age influence treatment
Resources:
Slides
Webcast